Volume 14 Supplement 1

Proceedings of the International Cancer Imaging Society (ICIS) 14th Annual Teaching Course

Open Access

Complications following locoregional therapy of renal cancer

Cancer Imaging201414(Suppl 1):O21

https://doi.org/10.1186/1470-7330-14-S1-O21

Published: 9 October 2014

Renal locoregional therapy or local ablation therapy, offers a valid solution for patients with small renal tumours that are not suitable surgical candidates.

Local ablation techniques are usually performed under imaging guidance and are minimal invasive. However, complications may occur even with this minimal invasive treatment.

The most frequent complication of ablation treatment is bleeding. Patients with renal cancer are often on antiplatelet or anticoagulant treatment for other reasons therefore at high risk of bleeding. The formation of a perirenal haematoma is reported in up to 30% from various authors [13]. Among the ablation methods cryotherapy appears to be leading to the formation of perirenal bleeding, probably due to the fact that a higher number of probes are usually required. Larger scale bleeding that would require transfusion and embolization is less frequent and is reported in up to 2% in various series [1, 4]. Bleeding in such cases may be taking origin form the intercostal arteries or from the ablation site of the renal parenchyma. Bleeding may also be expressed in the form of haematuria in up to 2.5% of the cases particularly when central lesions are treated [57]. However, haematuria may be transitional and urine may clear up after 24-48 hours.

Further reported complications may be adjacent organ thermal injury, particularly of the colon, that is reported in up to 1% in the various series [8]. In such cases thermal injury perforation and peritonitis may occur. Hydrodissection with glucose for RFA or CO2 dissection for cryoablation may prevent this complication.

Furthermore, thermal injury of the renal tract may occur and lead to the formation of a urinoma. Cold solution through an antegrade ureteric stent would protect the ureter from thermal injury when central lesions are treated.

Pain post treatment may also occur, however it is usually limited within the first two days. If persistent pain occurs then nerve injury needs to be suspected. Infection in up to 2% has been reported [9] however antibiotics are not routinely administered.

For the treatment of renal cancer surgical resection remains the standard treatment modality. Locoregional therapy has been frequently used to treat renal cancer in patients not suitable for surgical resection. This approach is minimally invasive, however it is not free of complications that need to be recognized and avoided.

Authors’ Affiliations

(1)
Department of Radiology, Cambridge University Hospitals NHS Foundation Trust

References

  1. Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR: Radiofrequency ablation of renal cell carcinoma: part 2. Lessons learned with ablation of 100 tumors. AJR 2005,185(1):72–80. 10.2214/ajr.185.1.01850072PubMedView ArticleGoogle Scholar
  2. Breen DJ, Railton NJ: Minimally invasive treatment of small renal tumors: trends in renal cancer diagnosis and management. Cardiovasc Interv Radiol 2010,33(5):896–908. 10.1007/s00270-010-9892-0View ArticleGoogle Scholar
  3. Varkarakis IM, Allaf ME, Inagaki T, Bhayani SB, Chan DY, Su L-M, et al.: Percutaneous radio frequency ablation of renal masses: results at a 2-year mean follow-up. J Urol 2005,174(2):456–460. 10.1097/01.ju.0000165655.91152.c5PubMedView ArticleGoogle Scholar
  4. Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE: Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR 2007,189(2):429–436. 10.2214/AJR.07.2258PubMedView ArticleGoogle Scholar
  5. Breen DJ, Rutherford EE, Stedman B, Roy-Choudhury SH, Cast JEI, Hayes MC, et al.: Management of renal tumors by image guided radiofrequency ablation: experience in 105 tumors. Cardiovasc Interv Radiol 2007,30(5):936–942. 10.1007/s00270-007-9090-xView ArticleGoogle Scholar
  6. Rhim H, Dodd GD, Chintapalli KN, Wood BJ, Dupuy DE, Hvizda JL, et al.: Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 2004,24(1):41–52. 10.1148/rg.241025144PubMedView ArticleGoogle Scholar
  7. Park BK, Kim CK: Complications of image-guided radiofrequency ablation of renal cell carcinoma: causes, imaging features and prevention methods. Eur Radiol 2009,19(9):2180–2190. 10.1007/s00330-009-1399-1PubMedView ArticleGoogle Scholar
  8. Rouviere O, Badet L, Murat FJ, Marechal JM, Colombel M, Martin X, Lyonnet D, Gelet A: Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection. Cardiovasc Interv Radiol 2008,31(3):595–603. 10.1007/s00270-007-9291-3View ArticleGoogle Scholar
  9. del Cura JL, Zabala R, Iriarte JI, Unda M: Treatment of renal tumors by percutaneous ultrasound-guided radiofrequency ablation using a multitined electrode: effectiveness and complications. Eur Urol 2010,57(3):459–465. 10.1016/j.eururo.2009.11.025PubMedView ArticleGoogle Scholar

Copyright

© Krokidis; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement